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Abstract
Purpose Previous studies have not defined the role of tele-
monitoring with educational tools in outpatients with ad-
vanced cancers. We tested the effectiveness of standardized
education and telemonitoring for improving pain, distress,
anxiety, depression, quality of life (QoL), and performance
in outpatients with advanced cancers.
Methods A total of 108 patients were randomly assigned to
receive pain education alone (control arm) or pain education
plus telemonitoring (experimental arm). Nursing specialists
provided video-assisted educational material in both arms
and daily telemonitoring for the first week in the experi-
mental arm. Assessment was performed at baseline and
1 week and included evaluations of pain (Brief Pain Inven-
tory, BPI), distress (Distress Thermometer, DT), anxiety,
and depression (Hospital Anxiety and Depression Scale,
HADS), QoL (QLQ-C30), and a Karnofsky score.
Results Overall (n=108), pain intensity was significantly im-
proved at 1 week, including worst pain (7.3 to 5.7, P<0.01)
and average pain (4.6 to 3.8, P<0.01). Additionally, anxiety
(HADS score≥11, 75 % to 56%, P<0.01), depression (HADS
score≥11, 73 % to 51 %, P<0.01), QoL (fatigue and insom-
nia), and the Karnofsky score (32 to 66, P<0.01) were also
significantly improved at 1 week. However, the level of dis-
tress did not improve. The telemonitoring plus standardized
education group showed more significant improvement in
portion of pain >4 on VAS scale (35 % vs. 19 %, P=0.02).
Conclusions Standardized pain education using nursing
specialists is an efficient way to improve not only pain itself
but also anxiety, depression, performance, and QoL. The
addition of telemonitoring helps to improve pain manage-
ment in the outpatient setting.
Keywords Cancer . Pain . Care management .
Telemonitoring . Quality of life
Introduction
Pain is one of the most common symptoms in patients with
advanced cancer, and more than one-third of patients with
pain rate it as moderate or severe [1]. Despite the existence
of well-documented guidelines for cancer pain [2-4], nearly
50 % of patients are undertreated [5]. Unrelieved pain is
associated with significant functional impairment, increased
anxiety and depression, reduced quality of life (QoL) and
might induce suicidal attempts [6-9].
Several factors have been identified as the main obstacles
to relieving cancer pain and can be categorized according to
patient, professional, and system perspectives [4, 7, 10-14].
Patients may be reluctant to communicate with physicians
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about pain because they consider the pain to represent pro-
gression of cancer, they may fear addiction or side effects of
medications, and they may desire to be good patients. Physi-
cians and nurses are not familiar with the principles of pain
management and have insufficient time.
Educational interventions including videos and booklets
have been applied to patients in previous research studies in
order to overcome barriers to controlling cancer-related pain
[14-17, 18-20]. Oliver et al. reported single exposure of indi-
vidualized pain education could improve pain control in can-
cer outpatients [15]. Miaskowski et al. (1, 2, 4, and 5 weeks)
and Yates et al. (1 and 2 weeks) provided multiple education
sessions to enable self-care in pain control [16, 17]. Syrjala et
al. utilized video tools with print materials [18]. These self-
administered educational tools composed of a booklet and
video helped patients to improve their knowledge and to
actively cope with pain management. Recently, telecare man-
agement has been shown to improve pain and depression in
patients with cancer [21]. Kroenke et al. improved patient
outcomes in pain and depression through multiple education
sessions regarding both pain and depression management,
combined with telemonitoring (1, 4, and 12 weeks). However,
previous studies have not defined the role of telemonitoring
with standardized educational tools in outpatients with ad-
vanced cancer. More than 80 % of the patients with advanced
cancer suffer from pain [4, 7], and there is insufficient time in
outpatient clinics and it is difficult to conduct short-term
follow-up; therefore, telemonitoring with educational tools
may be effective in palliative and outpatient settings. In this
study, our purpose was to evaluate whether standardized ed-
ucational tools with or without telemonitoring in outpatients
with advanced tumors could improve pain levels, pain inter-
ference, anxiety, depression, distress, performance, and QoL.
Patients and methods
Overview
This study was a randomized controlled trial. Between
October 2010 and July 2011, a total of 108 patients at Sever-
ance Hospital were randomly assigned to receive standardized
pain education only or standardized pain education plus tele-
monitoring for 1 week (Fig. 1). All patients were referred from
treating oncologists to a pain clinic. Outcomes were evaluated
at baseline and 1 week later in outpatient clinic. This study
was approved by the Institutional Review Board of Severance
Hospital (4-2010-0400).
Patients
Outpatients between 20 and 80 years old who had been
diagnosed with a stage IV advanced solid tumor and
experienced at least a moderate level of cancer-related pain,
defined as an average Visual Analog Scale (VAS) score ≥4
of 10 over the last 24 h, were eligible. All of the patients had
a life expectancy of more than 1 month. Both opioid-naïve
and opioid-tolerant patients were eligible. We excluded
patients who had cognitive, visual, or hearing impairment
and patients who received hospice care or consultation for
pain management, as these could be confounding factors.
All patients signed a written informed consent.
Intervention
At the time of enrollment, patients completed a baseline
demographic questionnaire and were randomly stratified to
either receive standardized pain education only or standard-
ized pain education plus telemonitoring using coin toss
simulation. For blinding, physicians and a nurse practitioner
(NP) were not informed of the randomization.
Fig. 1 Study overview
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In both the control and experimental arms, standardized
pain education included individualized education and advice
using a video-aided presentation and a booklet coached by NP
on the first visit. Video-aided presentation and a booklet were
totally based on the World Health Organization (WHO) pain
control guidelines and National Comprehensive Cancer Net-
work (NCCN) guideline. An NP who specialized in pain
management coached each patient and caregivers together
for approximately 30 min and checked the following compo-
nents: baseline questionnaire including performance, the role
of analgesics and misconception about using opioids, the
importance of pain assessment, the WHO pain control guide-
lines, and management of pain based on the NCCN guideline.
The booklet was composed of common pain management
misconceptions, including fear of addiction and being a bad
patient; pain assessment tools including VAS score; spaces for
writing a pain diary; and the algorithm flow sheet for pain
control. For individualization to each patient, a NP examined
baseline pain medication and the level of knowledge using
simple questions. Education was provided based on patients'
knowledge. An example of how to adjust the medication was
essentially given. After education and question and answer
sessions, the proper pain dosage was recommended to each
patient. The algorithm to determine pain control options was
based on NCCN guideline. If the patient was not tolerable in
oral intake, transdermal patch was recommended. After edu-
cation, no further education session was allowed in a pain
clinic after the first visit and routine practice by medical
oncologists was provided after the intervention.
In the experimental arm, telemonitoring regarding pain was
performed by an NP everyday for 1 week. The NP phoned the
patients and asked for their average VAS pain score and worst
VAS pain score in the last 24 h, providing patients a chance to
assess the severity of pain by themselves. The NP advised
patients whether to increase or decrease medication based on
the NCCN guidelines for pain management. The NP was
trained in pain management and had no specific training for
other psychosocial interventions. The NP conducting telemo-
nitoring is not the same person who performed the standard-
ized education at the baseline. Telemonitoring was provided to
patients for 1 week from the first visit.
Outcome measures
At baseline and 1 week after the first visit, we collected
information on pain, distress, anxiety and depression, QoL,
and performance status using a questionnaire in the outpa-
tient clinic. For pain, average pain at 2 months was also
collected. Outcome measures were as follows:
1. Pain
Wisconsin Brief Pain Inventory (BPI) is a widely used
standardized questionnaire for evaluating multiple aspects
of pain. It rates the severity of pain, including worst, least,
and average pain in the last 24 h, on a 0–10 scale along with
the degree of interference [22]. Higher scores represent
greater severity of symptoms.
2. Anxiety and depression
Hospital Anxiety and Depression Scale (HADS) is a
well-validated assessment questionnaire for anxiety and de-
pression in patients with medical illness [23]. It is composed
of seven depression and seven anxiety questions, respective-
ly. Each item is scored from 0 to 3, so that possible scores
range from 0 to 21 for each section. A score of 11 or higher
indicates a mood disorder.
3. Distress
Distress Thermometer (DT) is a well-validated tool for
evaluating distress from 0 (no distress) to 10 (extreme
distress) [24]. The 40-item Problem List was reviewed with
patients to identify their problems in five different catego-
ries: practical, family, emotional, spiritual/religious, and
physical issues.
4. QoL
The European Organization for Research and Treatment
of Cancer Quality of Life Questionnaire (EORTC QLQ-
C30) is a well-defined instrument containing 30 items for
cancer patients [25]. It measures global QoL, functioning,
and disease-related symptoms. A higher score for QoL
represents a higher QoL.
5. Performance
The Karnofsky performance score is a standardized tool
for evaluating functional impairment. It runs from 100 to 0,
and 100 means normal without complaints and 0 means
death. Generally, scores less than 40 represent an inability
to care for oneself and a requirement for hospital care.
Scores from 40 to 70 indicate patients are able to live at
home and care for most personal needs. Patients scoring
higher than 70 are able to carry on normal activity and to
work. Karnofsky performance rating criteria was provided
to each patient and performance score was measured by a
patient's self-report.
Statistical analysis
The primary endpoint of the study was a significant
reduction of 20 % in the average pain scale (more than
4) in the standardized education plus telemonitoring
group (30 %) compared to the standardized education
only group (50 %). Baseline demographic data between
the standardized education only and the standardized
education plus telemonitoring groups were compared us-
ing independent Student's t tests for continuous data and
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chi-squared test for categorical data. Changes from base-
line to 1 week were assessed within each group using
paired t tests for continuous data and generalized logit
model using generalized estimating equation approach for
categorical data. P values were two-sided with 0.05 set
as the level of significance. All calculations used actual
data and adjustments were not made for missing data.




One hundred and eight patients with newly diagnosed
stage IV advanced solid tumors and with at least a
moderate level of cancer-related pain were randomized
to either standardized education (n=54) or standardized
education plus telemonitoring (n=54) (Fig. 1). The de-
mographic characteristics of the patients are summarized
in Table 1. The overall mean age was 59.8 and there was
a higher proportion of men (67.6 %). The most common
cancer was gastrointestinal cancer, including stomach and
colon (n=39, 36.1 %), followed by lung (n=23, 21.3 %)
and head and neck cancer (n=17, 15.7 %). Most patients
were prescribed opioid analgesics (95.4 %). There were
no significant differences in any of the demographics
between the two groups.
Characteristics of the pain, distress, depression, anxiety,
QoL, and performance at baseline
Baseline characteristics for outcomes are shown Table 2.
Average and worst pain were 4.7 and 7.3, respectively, on a
0–10 scale, which indicates a substantial severity of pain.
Three-fourths of the patients had a mood disorder, such as
anxiety or depression. More than 90 % of patients had a
level of distress that was clinically significant (distress
scale≥4). The mean global QoL score was 41±18 on a 0–
100 scale, which is poorer than 56.3, which is the reference
value for recurrent or metastatic patients [26]. The mean
Karnofsky performance score was 32, which indicates a
requirement for special care and assistance. There were no
significant intergroup differences in any of the outcome
parameters at baseline.
Table 1 Baseline characteristics
of the 108 subjects
aIncludes pancreas (n=4), hepa-
tome (n=3), sarcoma (n=2),
primary peritoneal carcinomato-
sis (n=1), giant cell tumor of the
spine (n=1), and primary un-
known cancer (n=1)
bIncludes patients with heart fail-
ure, angina, and arrhythmia
cIncludes patients with chronic







Overall (n=108) P value
Age (median, years) 59.5 61.7 59.8 0.73
Male, no. (%) 38 (70.4) 35 (64.8) 73 (67.6) 0.54
Female, no. (%) 16 (29.6) 19 (35.2) 35 (32.4)
Body mass index
(BMI)
22.06 21.93 21.99 0.83
Type of cancer, no. (%)
Breast 2 (3.7) 4 (7.4) 6 (5.6) 0.48
Gastrointestinal tract 19 (35.2) 20 (37.0) 39 (36.1)
Genitourinary tract 4 (7.4) 7 (13.0) 11 (10.2)
Lung 15 (27.7) 8 (14.8) 23 (21.3)
Head and neck 7 (13.0) 10 (18.5) 17 (15.7)
Othera 7 (13.0) 5 (9.3) 12 (11.1)
Comorbidity, no. (%)
Diabetes mellitus 3 (5.6) 7 (13.0) 10 (9.3) 0.76




Heartb 2 (3.7) 2 (3.7) 4 (3.7)
Lungc 2 (3.7) 1 (1.8) 3 (2.8)
Chronic hepatitis 3 (5.6) 1 (1.8) 4 (3.7)
Chronic renal failure 0 1 (1.8) 1 (0.9)
Pain medication, no. (%)
Opioid analgesics 52 (96.3) 51 (94.4) 103 (95.4) 1.00
Nonopioid
analgesics
2 (3.7) 3 (5.6) 5 (4.6)
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Changes in pain, distress, depression, anxiety, QoL,
and performance at 1 week in all patients (n=108)
All pain scales were improved at 1 week, including worst (7.3
to 5.7, P<0.01) and average pain (4.6 to 3.8, P<0.01)
(Table 3). There was a significant reduction in the proportion
of patients whose pain scale was ≥4 (44 % to 28 %, P=0.01).
Interventions not only improved pain but also resolved other
clinical outcomes, including anxiety (HADS score≥11, 75 %
to 56 %, P<0.01), depression (HADS score≥11, 73 % to
51 %, P<0.01), and Karnofsky performance (32 to 66, P<
0.01). On the EORTC CTC-Q30 questionnaire, functional
scales, including emotional, cognitive, and social functions,
were improved. Symptomatic scales involving fatigue (68 to
63, P<0.01), pain (90 to 76, P<0.01), and insomnia (83 to 74,
P<0.01) were also improved, but constipation was increased
(53 to 72, P<0.01). The level of distress scale was not signif-
icantly decreased (distress scale≥4, 92 % to 87 %, P=0.27)
and the average number of problems did not change (21 of
total 40 problems, P=0.49). Improved patient outcomes did
not differ according to primary cancer types (data not shown).
Effect of the addition of telemonitoring for 1 week
in patients receiving standardized pain education
To test for an additional effect of telemonitoring for 1 week in
patients with standardized pain education, telemonitoring was
added to the experimental arm (n=54). Outcomes between
groups are shown in Table 4. The portion of the patients with
an average pain intensity ≥4 was significantly reduced in the
standardized education plus telemonitoring groups compared
to the standardized education only group (35 % to 19 %, P=
0.02). The average (−1.2 vs. −1.9) and worst (−0.7 vs. −1.2)
pain scales decreased more in the telemonitoring group, but
this was not statistically significant. Meanwhile, with regards
to improving painmanagement, the addition of telemonitoring
Table 2 Baseline values for outcome measures (n=108)




Overall (n=108) P value
BPI Average pain 4.6 4.8 4.7 0.46
Worst pain 7.1 7.4 7.3 0.72
Interference 5.6 5.8 5.7 0.56
HADS Anxiety, n (%), ≥11 42 (78 %) 39 (72 %) 81 (75 %) 0.50
Depression, n (%), ≥11 41 (76 %) 38 (70 %) 79 (73 %) 0.52
DT Distress scale, n (%), ≥4 48 (88.9) 51 (94.4) 99 (91.7) 0.30
No. of problems—mean 21 21 21 0.42
Global quality of life, mean (SD) 41 (18.5) 42 (17.5) 41 (18.0) 0.83
Karnofsky performance, mean 33 31 32 0.24
BPI Brief Pain Inventory, HADS Hospital Anxiety and Depression Scale, DT Distress Thermometer, SD standard deviation
Table 3 Overall course of clin-
ical outcomes between baseline
and 1 week
BPI Brief Pain Inventory, HADS
Hospital Anxiety and Depres-
sion Scale, DT Distress Ther-
mometer, QoL quality of life, SD
standard deviation
Clinical outcomes (n=108) Baseline 1 week P value
BPI Worst pain 7.3 5.7 (−1.6) <0.01
Average pain 4.6 3.8 (−0.8) <0.01
Interference 5.7 5.2 (−0.5) <0.01
No. of pain scale (4–10) 48 (44 %) 30 (28 %) 0.01
HADS Anxiety, n (%), ≥11 81 (75 %) 60 (56 %) <0.01
Depression, n (%), ≥11 79 (73 %) 55 (51 %) <0.01
DT Distress scale ≥4, n (%) 99 (92 %) 94 (87 %) 0.27
No. of problems—mean 21 21 0.49
QoL Physical functioning, mean (SD) 52 (24) 56 (22) 0.10
Role functioning, mean (SD) 36 (21) 38 (19) 0.27
Emotional functioning, mean (SD) 45 (26) 56 (22) <0.01
Cognitive functioning, mean (SD) 47 (21) 55 (19) <0.01
Social functioning, mean (SD) 27 (17) 33 (17) <0.01
Global quality of life, mean (SD) 41 (18) 39 (15) 0.19
Karnofsky performance score—mean (SD) 32 (9.1) 66 (8.6) <0.01
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for pain did not show further improvement of psychiatric and
other outcomes involving anxiety, depression, distress, QoL,
and performance scores. The average pain scale at 1 week was
maintained at 2 months in the standardized education group
(3.9 to 4.0) (Fig. 2). In the telemonitoring group, the improved
average pain scale at 1 week returned to the level of the
standardized education group (3.6 to 4.1).
Discussion
This study evaluated the effect of standardized pain educa-
tion using a video and a booklet and compared the addition-
al benefit of telemonitoring for pain in outpatients with
advanced cancer. Outcomes included measurements not on-
ly of pain itself but also anxiety, depression, distress, QoL,
and performance because we hypothesized pain improve-
ment influences psychosocial aspects of patients with ad-
vanced cancer. After 1 week of education, outcomes
including pain, anxiety, depression, QoL, and performance
improved. The addition of telemonitoring to standardized
pain education helped to improve pain management.
Patients with advanced cancer are frail and have a short
life expectancy. Interventions for pain in this group are
especially necessary as pain control would be the best of
practice increasing QoL in the absence of active treatment
options. We investigated this unmet need in terminal cancer
patients in the outpatient setting. Above all, simplicity
should be considered in this setting. Educational interven-
tions have improved cancer pain in previous studies [14-17],
and educational interventions involving both a video and
booklet have been shown to be more effective in pain
management than either alone [18, 19]. Recently, telecare
for pain and depression by Kroenke et al. was shown to
improve both outcomes in cancer patients compared to usual
care for pain control [21]. In other words, more care and
education naturally improve patient outcomes. However,
considering practical issues, especially in the outpatient
Table 4 Clinical outcomes of the two groups





BPI Worst pain Baseline 7.1 7.4 0.11
1 week 5.9 (−1.2) 5.5 (−1.9)
Average pain Baseline 4.6 4.8 0.24
1 week 3.9 (−0.7) 3.6 (−1.2)
Interference Baseline 5.6 5.8 0.44
1 week 5.2 (−0.4) 5.1 (−0.7)
No. of pain scale (4–10) Baseline 22 (41 %) 26 (48 %) 0.02
1 week 19 (35 %) 10 (19 %)
HADS Anxiety Baseline n (%), ≥11 42 (78 %) 39 (72 %) 0.34
1 week n (%), ≥11 29 (54 %) 31 (57 %)
Depression Baseline n (%), ≥11 41 (76 %) 38 (70 %) 0.64
1 week n (%), ≥11 28 (52 %) 27 (50 %)
DT Distress scale ≥4 Baseline n (%) 48 (89 %) 51 (94 %) 0.09
1 week n (%) 49 (91 %) 45 (83 %)
No. of problems—mean Baseline 21 21 0.35
1 week 21 20
QoL Physical functioning Baseline, mean (SD) 57 (22) 48 (25) 0.03
1 week, mean (SD) 55 (21) 56 (23)
Role functioning Baseline, mean (SD) 38 (20) 33 (23) 0.27
1 week, mean (SD) 38 (20) 38 (19)
Emotional functioning Baseline, mean (SD) 45 (25) 44 (27) 0.33
1 week, mean (SD) 54 (24) 58 (20)
Cognitive functioning Baseline, mean (SD) 49 (20) 45 (23) 0.13
1 week, mean (SD) 54 (17) 57 (20)
Social functioning Baseline, mean (SD) 27 (17) 28 (17) 0.69
1 week, mean (SD) 32 (18) 35 (17)
Global quality of life Baseline, mean (SD) 41 (19) 42 (18) 0.60
1 week, mean (SD) 38 (12) 40 (17)
Karnofsky performance score Baseline, mean (SD) 33 (9.4) 31 (8.7) 0.68
1 week, mean (SD) 65 (9.2) 66 (8.0)
BPI Brief Pain Inventory, HADS Hospital Anxiety and Depression Scale, DT Distress Thermometer, QoL quality of life, SD standard deviation
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setting with advanced cancer patients, we needed to develop
simple educational materials that are easily applicable to
frail patients. Distinct from the study performed by Kroenke
et al. [21], this study was focused on patients with terminal
stage and provided the role of telemonitoring in pain man-
agement only. We also examined the effect of pain improve-
ment on secondary outcomes (anxiety, depression, distress,
QoL, and performance).
Patients with stage IV cancer showed considerable pain
severity that impaired function (average pain of 4.7 in
Table 2), which was comparable to a previous report [27].
Most patients had accompanying anxiety (75 %), depression
(73 %), distress (92 %), and poor QoL and performance
necessitating special care by caregivers. Interestingly, inter-
vention for pain improved these physical and psychosocial
outcomes in 1 week (Table 3). It is accepted that educational
intervention improves knowledge of pain and analgesia and
reduces patient barriers to using opioid medication and
expressing pain intensity [14]. Several cross-sectional stud-
ies have shown that patients with pain have more frequent
anxiety and depression and lower levels of performance and
QoL than patients without pain [28-30]. However, it is
controversial whether pain has a causal relationship with
other factors, including anxiety, depression, and QoL. As
intervention in this study was confined to pain only, our
results may provide evidence that pain improvement indu-
ces betterment of physical and psychosocial factors with the
exception of distress (Table 3). Distress is defined as a
multifactorial unpleasant emotion combining psychological,
social, and spiritual factors [24], and it is presumed that pain
control alone is not sufficient for general distress improve-
ment. As the impact of pain control on other physical or
psychosocial factors might depend on the disease setting,
the type of intervention, and the type of questionnaire,
further studies are needed for each specific condition.
An effective schedule of educational intervention to im-
prove cancer pain may depend on demographic (e.g., age),
clinical (e.g., cancer type and stage), psychosocial (e.g.,
depression), and interindividual variability [31]. Our study
showed improvement in a relatively short period of 1 week.
Several explanations are possible. First, the patients' pain
intensity was relatively high and generally, pain affects
patients more significantly as it becomes more severe [27].
Second, the intervention could have a great impact on pal-
liative patients for whom active treatment is not possible.
The intervention might make patients perceive that they are
receiving care and have a positive effect on outcomes.
Third, allowing caregivers to receive standardized education
may help improve outcomes. Because patients usually need
a caregiver's assistance, most of the intervention was per-
formed with patients and their caregiver. Though one 30-
min session succeeded in improving outcomes, the effect of
education diminished after 2 months (Fig. 2), and this
implies multiple exposures might be necessary for palliative
patients. Multiple exposures could be substituted for peri-
odic telemonitoring. A subsequent trial is needed to identify
the optimal schedule and period of telemonitoring in
patients with advanced cancer.
The additional effect of telemonitoring was helpful for
improving primary pain management but not secondary
outcomes, such as distress, depression, anxiety, or QoL.
Given that the standardized pain educational program alone
improved pain and secondary outcomes, the additional yield
of telemonitoring seemed to be small. However, daily tele-
monitoring for about 10 min is a simple way to monitor
patients that does not require frequent visits to the clinic.
Telemonitoring for pain and other psychosocial factors like
depression also potentiate patient care [21].
There were two limitations in this study. First, the
addition of telemonitoring improved the portion of
Fig. 2 Average pain scale at
baseline, 1 week, and 2 months
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average pain ≥4 but did not show significant improvement of
other pain outcomes such as worst pain, average pain, and
interference. One potential reason is 1 week might be short
enough to show obvious differences. Opioid titration
demands time to be fully adjusted. As optimal average pain
score is less than 3 (mild pain), average pain of 3.6 in tele-
monitoring group after 1 week could be decreased to <3 if
the telemonitoring is continued. Another reason could be
owing to advanced disease setting. As pain in stage IV
cancers is often severe, a short-term effect would be minimal
between two groups. Long-term follow-up strategy should
be addressed. Second, the initial Karnofsky score (<40,
requires special care and assistance) could be lower than
the actual value. In spite of initial low performance score,
patients could undergo baseline screening with multiple var-
iable assessments. This discrepancy is likely due to self-
reported Karnofsky score. When patients were referred to a
pain clinic for the first time, they suffered from uncontrolled
pain. Unrelieved pain might affect their performance
negatively.
In conclusion, standardized pain education using a nurs-
ing specialist is an efficient way to improve not only pain
itself but also anxiety, depression, performance, and QoL in
1 week. The addition of telemonitoring helps to improve
pain management, and telemonitoring is a simple interven-
tion for outpatients with advanced tumors.
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